GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (NSE:SEQUENT) » Definitions » Days Sales Outstanding

Sequent Scientific (NSE:SEQUENT) Days Sales Outstanding : 82.50 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Sequent Scientific Days Sales Outstanding?

Sequent Scientific's average Accounts Receivable for the three months ended in Mar. 2025 was ₹3,632 Mil. Sequent Scientific's Revenue for the three months ended in Mar. 2025 was ₹4,017 Mil. Hence, Sequent Scientific's Days Sales Outstanding for the three months ended in Mar. 2025 was 82.50.

The historical rank and industry rank for Sequent Scientific's Days Sales Outstanding or its related term are showing as below:

NSE:SEQUENT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 81.55   Med: 92.02   Max: 120.25
Current: 81.55

During the past 13 years, Sequent Scientific's highest Days Sales Outstanding was 120.25. The lowest was 81.55. And the median was 92.02.

NSE:SEQUENT's Days Sales Outstanding is ranked worse than
58.53% of 955 companies
in the Drug Manufacturers industry
Industry Median: 72.47 vs NSE:SEQUENT: 81.55

Sequent Scientific's Days Sales Outstanding declined from Mar. 2024 (84.79) to Mar. 2025 (82.50).


Sequent Scientific Days Sales Outstanding Historical Data

The historical data trend for Sequent Scientific's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Days Sales Outstanding Chart

Sequent Scientific Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.75 87.41 86.24 90.15 82.21

Sequent Scientific Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.79 78.49 84.43 79.64 82.50

Competitive Comparison of Sequent Scientific's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Sequent Scientific's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequent Scientific's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sequent Scientific's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sequent Scientific's Days Sales Outstanding falls into.


;
;

Sequent Scientific Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sequent Scientific's Days Sales Outstanding for the fiscal year that ended in Mar. 2025 is calculated as

Days Sales Outstanding (A: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (3356.31 + 3631.7) / 2 ) / 15513.7*365
=3494.005 / 15513.7*365
=82.21

Sequent Scientific's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (0 + 3631.7) / 1 ) / 4017*365 / 4
=3631.7 / 4017*365 / 4
=82.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sequent Scientific  (NSE:SEQUENT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Sequent Scientific Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequent Scientific Business Description

Traded in Other Exchanges
Address
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines